e-SPACE Cardio-Renal-Metabolic 2024
Published: 29 March 2024
-
Views:
211
-
Likes:
7
-
Views:
211
-
Likes:
7
-
54m 56sPart 2 | Session 1 Plenary Session 6 – Anaemia and iron deficiency -
16m 6s
-
1h 10s
-
1h 8m 49sPart 2 | Session 4 Plenary Session 8 – Early intervention and intensive management
-
27m 17sPart 2 | Session 5 Effects of GLP- 1RA on kidney outcomes in CKD and T2D
-
1h 3m 47sPart 2 | Session 6 Plenary Session 9 – Precision medicine in CRM
-
1h 6sPart 1 | Session 1 Plenary Session 1 – Multidisciplinary implementation strategies Gerasimos Filippatos, Manisha Sahay, Gianluigi Savarese, Francesco Cosentino, Sam Seidu
-
28m 56sPart 1 | Session 2 Keynote Session – KDIGO guideline updates 2024 Paul Stevens
-
1h 2m 27sPart 1 | Session 3 Plenary Session 2 – Guideline directed therapy for CRM disease: the evidence base Intissar Haddiya, Lars H Lund, Marco Metra, Nikolaus Marx, Peter Rossing, Giuseppe Rosano
-
59m 47sPart 1 | Session 4 Plenary Session 3 – Managing the patients with CRM: who gets what, when and why? Gianluigi Savarese, Alice Cheng, Adeera Levin, Antonio Ceriello, Shelley Zieroth, Giuseppe Rosano
-
57m 21sPart 1 | Session 5 Plenary Session 4 – Weight homeostasis management in CRM disease (Organised with support from Charité Friends & Sponsors Trust) Scott Isaacs, Peter Rossing, Muthiah Vaduganathan, Stefan Anker, Javed Butler
Overview
KDIGO and Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Cardio-Renal-Metabolic (CRM) 2024.
A thoughtfully curated programme supported the exploration of how leading experts, in cardiology, nephrology and diabetology, treat the interrelated diseases.
This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Related sessions to e-SPACE Cardio-Renal-Metabolic 2024:
Learning Objectives
- Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality and reduced quality of life affecting individuals around the world
- Describe the complexity and interlink between the three conditions
- Discuss existing guidelines and best approaches for screening patients
- Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease and obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
- Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes
Target Audience
- Cardiologists
- Nephrologists
- Diabetologists
- General Practitioners (GPs)
- HF Specialists
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Ahmed Bennis
Professor of Cardiology
Prof Ahmed Bennis is Professor of Cardiology at Ibn Rochd University Hospital, Casablanca, MA.
He is also the past President of Moroccan Society of Cardiology.
Ileana L Piña
Dr Ileana L Pina is Professor at the Department of Medicine (Cardiology) and Professor in the Department of Epidemiology and Population Health at Montefiore Einstein Center for Heart and Vascular Care, US.
Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of examining recovery after exercise which could be translated to an additional parameter that may better predict prognosis of outcomes. In addition, there was a R21 to NHLBI to examine Vitamin D levels as another predictor from the HF ACTION database.
Dr Ileana L Pina is an Editorial Board member of Cardiac Failure Review.
Giulia Ferrannini
PHD Fellow
Dr Giulia Ferrannini is a specialist in internal medicine and a researcher at the Karolinska Hospital. Her research focusses on screening for diabetes and glucose disorders.
Dr Ferrannini studied medicine at University of Modena and Reggio Emilia in Italy. She then went on to study as a research fellow at the Naomi Berrie Diabetes Center at Columbia University in New York in 2014, before returning to Italy to Specialise in Internal Medicine at the University of Torino. She then travelled to Sweden following her graduation in 2019, where she is now dividing her time between research and the closed geriatrics department at Karolinska. She is also working as an attending physician and specialist in internal medicine at the Södertälje Hospital, Sweden.
Sources…
Chiadi Ndumele
Cardiologist
Dr Chiadi Ndumele is a Cardiologist at The Johns Hopkins Hospital, Maryland, US and the Robert E. Meyerhoff Assistant Professor in the Department of Medicine at Johns Hopkins University.
Dr Ndumele's research focuses on the relationship between obesity and cardiovascular disease, particularly heart failure.
Rodica Pop-Busui
Diabetologist
Prof Rodica Pop-Busui is a Diabetologist at University of Michigan Medical Center, Michigan, US.
Prof Pop-Busui is Vice Chair for Clinical Research in the Department of Internal Medicine and the Associate Director of Clinical Research, Mentoring and Development of the Elizabeth Caswell Diabetes Institute at the University of Michigan.
Her research interests include chronic complications of diabetes, diabetic kidney disease and cardiovascular disease.
Mitja Lainscak
Professor, Division of Cardiology
Prof Mitja Lainscak is a Professor in the Division of Cardiology at University of Ljubljana, Ljubljana, SI. He is also Director of the Slovenian Research Agency.
Comments